Cholinesterase inhibitor, used for the treatment of memory disorders in patients with Alzheimer’s disease and for the treatment of dementia in patients with Alzheimer’s Parkinson.

DRUG ACTIVE SUBSTANCE CONTENT PHARMACEUTICAL FORM       PACKAGING THERAPEUTICAL CATEGORY
Rivastigmine 2 mg/mL Oral solution FL x 50 mL
FL x 120 mL
Cholinesterase inhibitor